Berberis libanotica ehrenb extract shows anti-neoplastic effects on prostate cancer stem/progenitor cells

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  El Merahbi, Rabih ^a   Liu, Yen Nien ^b   Eid, Assaad ^a   Daoud, Georges ^a   Hosry, Leina ^c   Monzer, Alissar ^a   Mouhieddine, Tarek H ^a   Hamade, Aline ^c   Najjar, Fadia ^c   Abou Kheir, Wassim ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c LEBANESE UNIVERSITY   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERIS LIBANOTICA EXTRACT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BERBERIS; BERBERIS LIBANOTICA; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL RENEWAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MALE; MITOSIS INHIBITION; OXIDATIVE STRESS; PROSTATE CANCER; PROSTATE CANCER CELL LINE; TARGET CELL; TUMOR INVASION; APOPTOSIS; CANCER STEM CELL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PLANT ROOT; PROSTATE TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BERBERIS;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MALE; NEOPLASTIC STEM CELLS; OCTAMER TRANSCRIPTION FACTOR-3; PLANT EXTRACTS; PLANT ROOTS; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS;

EID: 84911397133     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0112453     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA: a cancer journal for clinicians 61: 69-90.
2. Bubendorf L, Schöpfer A, Wagner U, Sauter G, Moch H, et al. (2000) Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Human pathology 31: 578-583.
3. Ma I, Allan AL (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Reviews and Reports 7: 292-306.
4. Lou H, Dean M (2007) Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 26: 1357-1360.
5. Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, et al. (2013) Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme. PLoS One 8: e55062.
6. Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, et al. (2006) Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett 235: 84-92.
7. Maitland NJ, Collins AT (2008) Prostate cancer stem cells: a new target for therapy. J Clin Oncol 26: 2862-2870.
8. Sharifi N, Kawasaki BT, Hurt EM, Farrar WL (2006) Stem cells in prostate cancer: resolving the castrate-resistant conundrum and implications for hormonal therapy. Cancer Biol Ther 5: 901-906.
9. Schroeder A, Herrmann A, Cherryholmes G, Kowolik C, Buettner R, et al. (2013) Loss of androgen receptor expression promotes a stem-like cell phenotype in prostate cancer through STAT3 signaling. Cancer research.
10. Abou-Kheir WG, Hynes PG, Martin PL, Pierce R, Kelly K (2010) Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten 2/2 TP532/2 prostate cancer model. Stem Cells 28: 2129-2140.
11. Abou-Kheir W, Hynes PG, Martin P, Yin JJ, Liu Y-N, et al. (2011) Selfrenewing Pten2/2TP532/2 protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity. PloS one 6: e26112.
12. Luk SU, Yap WN, Chiu YT, Lee DT, Ma S, et al. (2011) Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. International Journal of Cancer 128: 2182-2191.
13. Luk S-U, Lee TK-W, Liu J, Lee DT-W, Chiu Y-T, et al. (2011) Chemopreventive effect of PSP through targeting of prostate cancer stem celllike population. PloS one 6: e19804.
14. Zhang L, Li L, Jiao M, Wu D, Wu K, et al. (2012) Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway. Cancer Letters 323: 48-57.
15. Bonesi M, Loizzo MR, Conforti F, Passalacqua NG, Saab A, et al. (2013) Berberis aetnensis and B. libanotica: a comparative study on the chemical composition, inhibitory effect on key enzymes linked to Alzheimer's disease and antioxidant activity. Journal of Pharmacy and Pharmacology 65: 1726-1735.
16. Marc EB, Nelly A, Annick D-D, Frederic D (2008) Plants used as remedies antirheumatic and antineuralgic in the traditional medicine of Lebanon. Journal of ethnopharmacology 120: 315-334.
17. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytotherapy research 22: 999-1012.
18. Zovko Končić M, Kremer D, Karlović K, Kosalec I (2010) Evaluation of antioxidant activities and phenolic content of Berberis vulgaris L. and Berberis croatica Horvat. Food and chemical toxicology 48: 2176-2180.
19. Kim S, Choi JH, Kim JB, Nam SJ, Yang J-H, et al. (2008) Berberine suppresses TNF-α-induced MMP-9 and cell invasion through inhibition of AP-1 activity in MDA-MB-231 human breast cancer cells. Molecules 13: 2975-2985.
20. Singh J, Kakkar P (2009) Antihyperglycemic and antioxidant effect of Berberis aristata root extract and its role in regulating carbohydrate metabolism in diabetic rats. Journal of ethnopharmacology 123: 22-26.
21. Roberts MF, Wink M (1998) Alkaloids: biochemistry, ecology, and medicinal applications: Springer.
22. Aniszewski T (2007) Alkaloids-Secrets of Life:: Aklaloid Chemistry, Biological Significance, Applications and Ecological Role: Elsevier.
23. Huang M, Gao H, Chen Y, Zhu H, Cai Y, et al. (2007) Chimmitecan, a novel 9- substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clinical cancer research 13: 1298-1307.
24. Li W, Shao Y, Hu L, Zhang X, Chen Y, et al. (2007) BM6, a new semi-synthetic vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles. Cancer Biology & Therapy 6: 787-794.
25. Singh T, Vaid M, Katiyar N, Sharma S, Katiyar SK (2011) Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E2 and prostaglandin E2 receptors. Carcinogenesis 32: 86-92.
26. Ho Y-T, Yang J-S, Lu C-C, Chiang J-H, Li T-C, et al. (2009) Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model. Phytomedicine 16: 887-890.
27. Refaat A, Abdelhamed S, Yagita H, Inoue H, Yokoyama S, et al. (2013) Berberine enhances tumor necrosis factor-related apoptosis-inducing ligandmediated apoptosis in breast cancer. Oncology letters 6: 840-844.
28. Liu B, Wang G, Yang J, Pan X, Yang Z, et al. (2011) Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes. PloS one 6: e21416.
29. Peng P-L, Hsieh Y-S, Wang C-J, Hsu J-L, Chou F-P (2006) Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicology and applied pharmacology 214: 8-15.
30. Esseily F, El Ezzy M, Gali-Muhtasib H, Safi S, Esseily J, et al. (2012) The ethanol fraction from the stem of Berberis libanotica inhibits the viability of adult T cell leukemia. Minerva Biotecnologica 24: 129-133.
31. Eid AA, Ford BM, Bhandary B, de Cassia Cavaglieri R, Block K, et al. (2013) Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury. Diabetes 62: 2935-2947.
32. Bournine L, Bensalem S, Peixoto P, Gonzalez A, Maiza-Benabdesselam F, et al. (2013) Revealing the anti-tumoral effect of Algerian Glaucium flavum roots against human cancer cells. Phytomedicine.
33. Slaninová I, Pěnčková K, Urbanová J, Slanina J, Táborská E (2013) Antitumour activities of sanguinarine and related alkaloids. Phytochemistry Reviews: 1-18.
34. Yu J, Ma Y, Drisko J, Chen Q (2013) Antitumor Activities of Rauwolfia vomitoria Extract and Potentiation of Carboplatin Effects Against Ovarian Cancer. Current Therapeutic Research 75: 8-14.
35. Kaseb AO, Chinnakannu K, Chen D, Sivanandam A, Tejwani S, et al. (2007) Androgen receptor and E2F-1 targeted thymoquinone therapy for hormonerefractory prostate cancer. Cancer Res 67: 7782-7788.
36. Wang Y, Liu Q, Liu Z, Li B, Sun Z, et al. (2012) Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 734: 20-29.
37. Rafi MM, Vastano BC, Zhu N, Ho C-T, Ghai G, et al. (2002) Novel polyphenol molecule isolated from licorice root (Glycrrhiza glabra) induces apoptosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. Journal of agricultural and food chemistry 50: 677-684.
38. Corcoran C, Rani S, O'Brien K, O'Neill A, Prencipe M, et al. (2012) Docetaxelresistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PloS one 7: e50999.
39. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, et al. (2012) Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehog-dependent tumor-initiating cells. Cancer cell 22: 373-388.